Customized research for MLNT vs. MESO!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for MLNT vs. MESO.


↗ Join Our Free Email Newsletter.




Melinta Therapeutics Inc. vs. Mesoblast Limited

Industry Match! Industry of Both MLNT and MESO:

Health Care/Life Sciences

MLNT
Data Last Updated: 2 days ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 22M


P/E: N/A

P/S: 0.23

Q P/B: N/A

Y Rev: 96.43M

Q Rev: 15.87M

Beta: 6.80

MLNT Share Stats

Outstanding Shares

11.78M

Float Shares

10.37M

Percent of Float Short

20.47%

MLNT Insider Stats

Percent Outstanding Insider Ownership

8.55%

Percent Outstanding Institution Ownership

27.56%

MLNT Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

MLNT in Pulse Portal

Stream of Posts

MLNT Symbol Page

Share MLNT Insights

Express Sentiment

'Buy' or 'Sell' MLNT

MLNT Profile

CEO

Ms. Jennifer A. Sanfilippo

Exchange

Nasdaq

Employees

290.00

About

Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv,...

MLNT Financials

Annual Financials

Income Statement

Revenue

96.43M

Net Income

(157.19M)

Cash Flow Statement

Change in Cash / Investments

(46.58M)

Balance Sheet

Cash / Investments

81.81M

Short Term Debt

None

Long Term Debt

110.48M

Total Current Assets

149.48M

Total Current Liabilities

133.61M

Total Assets

441.59M

Total Liabilities

251.53M

Stockholder Equity

190.06M

Quarterly Financials

Income Statement

Q Revenue

15.87M

Q Net Income

(213.38M)

Cash Flow Statement

Q Change in Cash / Investments

(26.82M)

Balance Sheet

Q Cash / Investments

63.52M

Q Short Term Debt

7.82M

Q Long Term Debt

152.79M

Q Total Current Assets

131.27M

Q Total Current Liabilities

128.05M

Q Total Assets

228.49M

Q Total Liabilities

289.02M

Q Stockholder Equity

(60.53M)

MLNT Charts

10-Year Chart

MLNT 10-Year Chart

5-Year Chart

MLNT 5-Year Chart

1-Year Chart

MLNT 1-Year Chart

6-Month Chart

MLNT 6-Month Chart

3-Month Chart

MLNT 3-Month Chart

1-Month Chart

MLNT 1-Month Chart

1-Day Chart

MLNT 1-Day Chart

MESO
Data Last Updated: 15 hours ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 650M


P/E: N/A

P/S: 29.04

Q P/B: 0.92

Y Rev: 22.38M

Q Rev: 24.87M

Beta: 1.61

MESO Share Stats

Outstanding Shares

99.73M

Float Shares

N/A

Percent of Float Short

N/A

MESO Insider Stats

Percent Outstanding Insider Ownership

0%

Percent Outstanding Institution Ownership

4.56%

MESO Social Stats

Followers

3

B/S Rating Today

0

B/S Rating All-Time

+6

More Social Data

MESO in Pulse Portal

Stream of Posts

MESO Symbol Page

Share MESO Insights

Express Sentiment

'Buy' or 'Sell' MESO

MESO Profile

CEO

Mr. Joseph R. Swedish

Exchange

Nasdaq

Employees

83.00

About

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated,...

MESO Financials

Annual Financials

Income Statement

Revenue

22.38M

Net Income

(125.57M)

Cash Flow Statement

Change in Cash / Investments

17.71M

Balance Sheet

Cash / Investments

71.86M

Short Term Debt

19.96M

Long Term Debt

95.87M

Total Current Assets

89.09M

Total Current Liabilities

63.31M

Total Assets

1.02B

Total Liabilities

337M

Stockholder Equity

685.5M

Quarterly Financials

Income Statement

Q Revenue

24.87M

Q Net Income

(8M)

Cash Flow Statement

Q Change in Cash / Investments

(23.18M)

Balance Sheet

Q Cash / Investments

51.21M

Q Short Term Debt

27.95M

Q Long Term Debt

96.2M

Q Total Current Assets

89.84M

Q Total Current Liabilities

103.92M

Q Total Assets

969.36M

Q Total Liabilities

264.87M

Q Stockholder Equity

704.5M

MESO Charts

10-Year Chart

MESO 10-Year Chart

5-Year Chart

MESO 5-Year Chart

1-Year Chart

MESO 1-Year Chart

6-Month Chart

MESO 6-Month Chart

3-Month Chart

MESO 3-Month Chart

1-Month Chart

MESO 1-Month Chart

1-Day Chart

MESO 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon